Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The British Veterinary Journal|May 1, 1990
Immunochemotherapy (thymostimulin/cyclophosphamide) in dogsJ A Montoya, E M Martínez, M Rodríguez, et al.
Cellular and Molecular Life Sciences : CMLS|March 5, 2003
Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitisM Penkowa, C Espejo, E M Martínez-Cáceres, et al.
European Journal of Neurology|October 8, 2004
Differences between hypertensive and non-hypertensive ischemic strokeA Arboix, H Roig, R Rossich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosisI Durán, E M Martínez-Cáceres, L Brieva, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 17, 2010
Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicinM P Rivera-Fillat, F Reig, E M Martínez, et al.
Neurologia (Barcelona, Spain)|June 23, 1999
[Meningitis by Cryptococcus neoformans in patients with HIV infection]E M Martínez Fernández, L F López-Cortés, C Regordan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosisC Espejo, L Brieva, G Ruggiero, et al.
European Journal of Paediatric Dentistry|January 17, 2022
Characteristics of dental arches and occlusion in children born prematurely. A case-control studyA J López-Jiménez, P Beltri Orta, E M Martínez Pérez, et al.
Journal of Neurology|June 3, 2000
Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta?X Montalban, I Durán, J Río, et al.
Pageof 4